Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
J&J Seeks Earlier Use of Tecvayli in Europe Following US Myeloma Approval
Johnson & Johnson has submitted an application to European regulators to expand the use of its myeloma drug Tecvayli as a monotherapy after just one prior treatment. This follows recent U.S. approval for a Tecvayli combination and is supported by trial data showing a 71% reduction in disease progression risk.
Teradyne Files German Copyright Suit Against Chinese Robotics Firm Elite Robots
Teradyne Robotics has initiated a copyright lawsuit in Germany against the German subsidiary of China's Elite Robots, claiming unauthorized use of Universal Robots software. The company also notified European safety authorities about potential issues with Elite Robots' machines.
Exxon Mobil Seeks Shareholder Nod to Reincorporate in Texas
Exxon Mobil Corporation has proposed shifting its legal headquarters from New Jersey to Texas, a move requiring shareholder approval at its upcoming annual meeting. The change would align its legal home with its operational hub but not affect physical assets or employment.
Indonesia's Youth Social Media Ban Puts Alphabet's YouTube Revenue at Risk
Indonesia is set to enforce a ban on users under 16 from high-risk social media platforms, including YouTube, starting March 28. The rule directly challenges a business segment that generated over $60 billion for Alphabet last year.
AWS Migrates Defense AI Work from Anthropic Following Pentagon Risk Designation
Amazon Web Services is moving defense-related AI workloads away from Anthropic's Claude model following a Pentagon supply-chain risk designation. The shift comes as Anthropic sues the government over the ban.
SSE Executives Acquire Shares Ahead of Major Grid Investment Phase
SSE PLC disclosed that CEO Martin Pibworth and six other senior executives acquired shares through the company's all-employee plan ahead of a closed period. The move comes as SSE embarks on a £33 billion, five-year grid investment program.
LSEG Unveils Comprehensive ESG Scoring Ahead of EU Regulatory Deadline
London Stock Exchange Group has introduced a major ESG scoring and analytics platform, covering thousands of companies and bonds, as it prepares for upcoming European sustainability regulations. The launch follows a significant share repurchase program and ongoing investor pressure for growth.
Ford Issues Massive Recall for 1 Million Vehicles, Stock Dips
Ford Motor Company is initiating a recall covering approximately 1.02 million vehicles in the United States due to windshield wiper motor and rear suspension issues. The automaker's shares declined about 1% following the announcement.
Atara Biotherapeutics Surges on FDA Leadership Shift, EBVALLO Review in Focus
Atara Biotherapeutics shares surged 18% Monday following news of an upcoming FDA leadership change, reviving investor hope for a reconsideration of its rejected EBVALLO therapy for a rare blood cancer.
Reviva Pharma Enacts Reverse Split to Fend Off Nasdaq Delisting
Reviva Pharmaceuticals Holdings has implemented a 1-for-20 reverse stock split to boost its share price and avoid a Nasdaq delisting, with a critical compliance deadline of March 27. The company also faces financing challenges for an additional Phase 3 trial of its schizophrenia drug candidate, brilaroxazine.
uniQure Shares Soar on FDA Leadership Shift Amid Gene Therapy Dispute
uniQure shares jumped 34% in premarket trading following news that FDA biologics chief Vinay Prasad will depart in April. The move comes amid a regulatory standoff over the company's Huntington's disease gene therapy.
Palantir Faces Pentagon AI Ban Fallout as Defense Tech Reliance Questioned
Palantir Technologies confronts new risks as the U.S. Pentagon designates AI supplier Anthropic a supply-chain threat, raising concerns over its defense software dependencies. Broader market jitters add to the pressure.